Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.51 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.47 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | TLR4 | O00206 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | IGF1R | P08069 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | NOS1 | P29475 | 2/20 | 0.42 |
| ▸ | NOS2 | P35228 | 2/20 | 0.42 |
| ▸ | MT-CO2 | P00403 | 2/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.41 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15874652 | 1.00 | SLC18A3 (0.51) | SLC18A3MCL1MAPTDDB1CRBN | |
| SCHEMBL190786 | 1.00 | SLC18A3 (0.51) | SLC18A3MCL1MAPTDDB1CRBN | |
| SCHEMBL28417815 | 0.98 | SLC18A3 (0.50) | SLC18A3MCL1MAPTDDB1CRBN | |
| SCHEMBL15874614 | 0.98 | SLC18A3 (0.50) | SLC18A3MCL1MAPTDDB1CRBN | |
| SCHEMBL30882060 | 0.98 | SLC18A3 (0.50) | SLC18A3MCL1MAPTDDB1CRBN | |
| Hydrogen Peroxide SCHEMBL14842506 | 0.98 | MCL1 (0.53) | SLC18A3MCL1MAPTDDB1CRBN | |
| SCHEMBL4063122 | 0.98 | SLC18A3 (0.50) | SLC18A3MCL1MAPTDDB1CRBN | |
| SCHEMBL15660493 | 0.98 | SLC18A3 (0.50) | SLC18A3MCL1MAPTDDB1CRBN | |
| Formaldehyde SCHEMBL28906285 | 0.96 | SLC18A3 (0.49) | SLC18A3MCL1MAPTDDB1CRBN | |
| SCHEMBL361599 | 0.94 | DDB1 (0.48) | SLC18A3MCL1MAPTDDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023154450-A2 | (AMPA-PAM)-NMDA RECEPTOR ANTAGONIST COMBINATION THERAPY FOR TREATMENT OF MENTAL CONDITIONS AND DISORDERS | GILGAMESH PHARMACEUTICALS, INC. (US) | 2023-08-17 | — | — | WO | disclosed |
| WO-2022261263-A1 | METHODS OF TREATING NEUROPSYCHIATRIC DISORDERS | GILGAMESH PHARMACEUTICALS, INC. (US) | 2022-12-15 | — | — | WO | disclosed |
| WO-2021134086-A1 | ARYLCYCLOHEXYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS | GILGAMESH PHARMACEUTICALS, INC. (US) | 2021-07-01 | — | — | WO | disclosed |
| EP-2957575-B1 | OPTICALLY ACTIVE POLY(DIPHENYLACETYLENE) COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF AS OPTICAL ISOMER SEPARATING AGENT | NAT UNIV CORP KANAZAWA UNIV (JP) | 2017-10-18 | — | — | EP | disclosed |
| EP-2594550-B1 | METHOD FOR OXIDIZING ALCOHOLS | UNIV TOHOKU (JP) | 2016-10-12 | — | — | EP | disclosed |
| US-8871981-B2 | Method for oxidizing alcohols | TOHOKU UNIVERSITY (JP) | 2014-10-28 | — | — | US | disclosed |
| US-8871981-B2 | Method for oxidizing alcohols | TOHOKU UNIVERSITY (JP) | 2014-10-28 | — | — | US | disclosed |
| US-20130172543-A1 | METHOD FOR OXIDIZING ALCOHOLS | TOHOKU UNIVERSITY (JP) | 2013-07-04 | — | — | US | disclosed |
| US-20130172543-A1 | METHOD FOR OXIDIZING ALCOHOLS | TOHOKU UNIVERSITY (JP) | 2013-07-04 | — | — | US | disclosed |
| EP-2594550-A1 | METHOD FOR OXIDIZING ALCOHOLS | Tohoku University (JP) | 2013-05-22 | — | — | EP | disclosed |
| US-5334741-A | Contacting surface of substrate with phosphoramidate solution, heating to thermolyse and generate metaphosphate which phosphorylates substrate | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1994-08-02 | — | — | US | disclosed |
| WO-1994002226-A1 | PHOSPHORYLATION WITH MONOMERIC METAPHOSPHATES | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1994-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172543-A1 | METHOD FOR OXIDIZING ALCOHOLS | ADH1A, ADH1C, ADH5 | SLC18A3 2912/4885MCL1 3151/4885MAPT 2182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.